NEW YORK (GenomeWeb News) – GeneGo said today that it plans to use a Phase I Small Business Innovation Research grant from the National Cancer Institute to develop cancer data analysis software in a collaboration with the Dana-Farber Cancer Institute.

 

GeneGo said it is developing a system called MetaMiner that will be tailored for biologists, clinicians, and chemists involved in cancer research. The software will combine pathway and network analysis tools, serve as a data repository, and include certain statistical tools.